Article

Medicare Says "Yes" to LDCT in Lung Cancer

CMS announced today that low-dose computed tomography screening will now be reimbursed once a year by Medicare as a preventive service benefit, despite an advisory panel recommending against the screening back in April 2014.

Medicare announced today that it will cover low-dose computed tomography (LDCT) screening. The memo released today by CMS states that the available evidence is sufficient to include preventive LDCT once a year as an additional preventive service benefit. The coverage benefit, of course, has to be met with certain criteria that have been laid down by the CMS. The beneficiary must be:

  1. 55 to 74 years of age
  2. Asymptomatic for lung disease
  3. Current smoker or should have quit smoking within the last 15 years.

Further, the initial screen would require a written order for LDCT during a lung cancer screening counseling and shared decision making visit, furnished by a physician or qualified physician practitioner. For subsequent screens, the beneficiary must receive a written order, which may be furnished during any appropriate visit with a physician or qualified physician practitioner.

Additionally, the screening radiologist and the imaging center have to meet certain eligibility criteria for the coverage decision to be made.

This announcement contradicts the recommendation by a CMS advisory panel back in April 2014. The panel concluded that annual LDCT lung cancer screening for high-risk individuals doesn't have enough evidence for benefit over harms to be covered by.

The proposed coverage decision is now open for public comments.

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Dr Johnie Rose
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Cathy Eng, MD, FACP, FASCO
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo